This isn’t just about Texas throwing money at a fringe idea. It’s a sign that mainstream institutions are starting to take psychedelics seriously as medicine, particularly for tough-to-treat conditions like PTSD. Veterans’ advocacy groups have pushed for this, arguing that traditional treatments fall short. But the big question remains: Will the science back up the hype, or will safety concerns keep ibogaine on the sidelines? Either way, it’s a step toward rethinking how we approach mental health.

Texas is making a bold move by approving $50 million to study ibogaine, a psychedelic substance derived from a West African shrub. The research will focus on its potential to treat PTSD and traumatic brain injuries, especially in veterans. While ibogaine is illegal in the U.S., this funding signals growing openness to alternative therapies—though skeptics warn about safety risks.

Texas OK’s $50 Million for Ibogaine Research

Was this article worth reading? Share it